Northrop Grumman

Using the publicly available ImmPort database, researchers standardized and analyzed immune-related data for more than 10,300 healthy individuals.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop

Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats.

The companies will use Luminex's xMAP technology to develop an automated biothreat detection tool for a US biosecurity network.

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.